Literature DB >> 31186865

Treatment of nonalcoholic fatty liver disease: Role of dietary modification and exercise.

Angelo H Paredes1, Dawn M Torres1, Stephen A Harrison2.   

Abstract

Entities:  

Year:  2012        PMID： 31186865      PMCID： PMC6499276          DOI： 10.1002/cld.63

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  10 in total

1.  Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis.

Authors:  Jeffrey W Molloy; Christopher J Calcagno; Christopher D Williams; Frances J Jones; Dawn M Torres; Stephen A Harrison
Journal:  Hepatology       Date:  2011-12-22       Impact factor: 17.425

2.  Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.

Authors:  Kristin D Kistler; Elizabeth M Brunt; Jeanne M Clark; Anna Mae Diehl; James F Sallis; Jeffrey B Schwimmer
Journal:  Am J Gastroenterol       Date:  2011-01-04       Impact factor: 10.864

3.  One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.

Authors:  Mary Ann Huang; Joel K Greenson; Cewin Chao; Lilian Anderson; Debra Peterman; Jon Jacobson; Dawn Emick; Anna S Lok; Hari S Conjeevaram
Journal:  Am J Gastroenterol       Date:  2005-05       Impact factor: 10.864

4.  Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

Authors:  Christopher D Williams; Joel Stengel; Michael I Asike; Dawn M Torres; Janet Shaw; Maricela Contreras; Cristy L Landt; Stephen A Harrison
Journal:  Gastroenterology       Date:  2010-09-19       Impact factor: 22.682

5.  Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial.

Authors:  Michael L Dansinger; Joi Augustin Gleason; John L Griffith; Harry P Selker; Ernst J Schaefer
Journal:  JAMA       Date:  2005-01-05       Impact factor: 56.272

6.  Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease.

Authors:  Manal F Abdelmalek; Ayako Suzuki; Cynthia Guy; Aynur Unalp-Arida; Ryan Colvin; Richard J Johnson; Anna Mae Diehl
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

7.  Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.

Authors:  Stephen A Harrison; Will Fecht; Elizabeth M Brunt; Brent A Neuschwander-Tetri
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

8.  Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study.

Authors:  Shira Zelber-Sagi; Dorit Nitzan-Kaluski; Rebecca Goldsmith; Muriel Webb; Laurie Blendis; Zamir Halpern; Ran Oren
Journal:  J Hepatol       Date:  2007-08-14       Impact factor: 25.083

9.  Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats.

Authors:  James R Levy; John N Clore; Wayne Stevens
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

10.  Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss.

Authors:  Kate Hallsworth; Gulnar Fattakhova; Kieren G Hollingsworth; Christian Thoma; Sarah Moore; Roy Taylor; Christopher P Day; Michael I Trenell
Journal:  Gut       Date:  2011-06-27       Impact factor: 23.059
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.